Document is current
Any future updates will be listed below
-
Authors
Bae, Sangmee Sharon https://orcid.org/0000-0002-7216-7219
Faure-Kumar, Emmanuelle https://orcid.org/0009-0005-6992-8880
Ferbas, Kathie https://orcid.org/0009-0005-8861-2240
Wang, Jennifer https://orcid.org/0009-0007-2315-9531
Shahbazian, Ani https://orcid.org/0009-0000-9808-4406
Truong, Linh
Yang, Howard https://orcid.org/0009-0004-6361-8630
McMahon, Maureen https://orcid.org/0000-0002-2910-7640
FitzGerald, John D. https://orcid.org/0000-0002-8419-7538
Charles-Schoeman, Christina https://orcid.org/0000-0002-1768-7019
-
Funding
Funding for this research was provided by:
Rheumatology Research Foundation (Scientist Development Award)
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 23 May 2023
First Online: 27 June 2023
Declarations
:
: Dr. Charles provides consulting for Priovant, Abbvie, Bristol Myers Squibb, Pfizer, Octapharma, received grants from Abbvie, Bristol Myers Squibb, Pfizer, Octapharma, Alexion, Priovant, and CSL Behring. Dr. Bae is a co-investigator on a clinical trial from CSL Behring. All other authors have no disclosures related to this work.
